NephroPlus Launches Rs 871-Crore IPO With Price Band Of Rs 438-460

WOWLY- Your AI Agent Apr 02, 2026 1,250 Views

Dialysis services provider Nephrocare Health Services Ltd, known by its brand NephroPlus, will open its Rs 871-crore Initial Public Offering (IPO) on December 10, 2025. The issue, priced at Rs 438-460 per share, includes both fresh equity and an Offer For Sale, closing on December 12.

NephroPlus, India’s largest dialysis network, is set to make its public market debut with a Rs 871-crore IPO. The Hyderabad-based company announced that the subscription window will open on December 10 and close on December 12, with anchor bidding scheduled for December 9. The IPO comprises a fresh issue of shares worth Rs 353.4 crore and an Offer For Sale (OFS) of 1.12 crore shares valued at Rs 517.6 crore at the upper end of the price band.

Key highlights from the announcement include

The IPO price band has been fixed at Rs 438-460 per share, valuing the company at over Rs 4,600 crore.
Anchor bidding will take place on December 9, followed by public subscription from December 10-12.
The fresh issue will raise Rs 353.4 crore, earmarked for expansion of dialysis clinics, debt repayment, and general corporate purposes.
The OFS will see promoters and investors including Investcorp Private Equity Fund II, Healthcare Parent, Investcorp Growth Opportunity Fund, Edoras Investment Holdings, IFC, and 360 One Special Opportunities Fund divest part of their holdings.
NephroPlus operates a global network of 519 dialysis clinics, including 51 in the Philippines, making it one of Asia’s largest providers of dialysis care.
The company, founded in 2009, has built a strong reputation for affordable and quality dialysis services across India and abroad.
Listing of shares is expected on December 17, 2025, subject to regulatory approvals.

The IPO reflects investor confidence in India’s growing healthcare services sector, particularly in specialized care such as dialysis. With rising demand for chronic kidney disease treatment and limited infrastructure, NephroPlus is well-positioned to expand its footprint and strengthen its leadership in the segment.

Sources: Reuters, The Week, Free Press Journal, Economic Times, Business Today, Mint

Stay Ahead – Explore Now! European Stocks Rally as Markets Eye Peace Prospect, SpaceX Debut